Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

ADM scaffolds help skin heal by promoting a healing-type immune response.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.